An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis

Allergy and Asthma Proceedings

Volumn 31, Issue 6, 2010, Pages 483-492

  Maspero, Jorge F ^a   Walters, Richard D ^b   Wu, Wei ^c   Philpot, Edward E ^c   Naclerio, Robert M ^d   Fokkens, Wytske J ^e  

^a Fundacion CIDEA   (Argentina)

^b GLAXOSMITHKLINE   (France)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE FUROATE; NOSE SPRAY; PLACEBO; RAGWEED ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ENVIRONMENTAL EXPOSURE; EPIPHORA; EYE BURNING; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASAL PRURITUS; NOSE CONGESTION; OCULAR PRURITUS; RAGWEED POLLEN; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SNEEZING; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ALLERGENS; AMBROSIA; ANDROSTADIENES; ANTIGENS, PLANT; CEDRUS; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL SPRAYS; POLLEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, SEASONAL;

EID: 78650455496     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3397     Document Type: Article

References (23)

1. Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 62(suppl 85):17-25, 2007.
2. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 62(suppl 85):9-16, 2007.
3. Bousquet J, Van CP, and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108(suppl):S147-S334, 2001.
4. 2LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
5. Bauchau V, and Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24:758-764, 2004.
6. Bachert C, van Cauwenberge P, Olbrecht J, et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 61:693-698, 2006.
7. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. Joint Task Force on Practice Parameters. J Allergy Clin Immunol 122:S1-S84, 2008.
8. Global Alliance against Chronic Respiratory Diseases (GARD): General meeting report. Seoul, Republic of Korea, June 1-2, 2007. Available online at www.who.int/gard/publications/MtgReport-GMSeoul-Final.pdf; accessed January 11, 2010.
9. Schoenwetter WF, Dupclay L, Appajosyula S, et al. Economic impact and quality of life burden of allergic rhinitis. Curr Med Res Opin 20:305-317, 2004.
10. Reed SD, Lee TA, and McCrory DC. The economic burden of allergic rhinitis. Pharmacoeconomics 22:345-361, 2004.
11. Scadding GK, and Williams A. The burden of allergic rhinitis as reported by UK patients compared with their doctors. Rhinology 46:99-106, 2008.
12. Bousquet J, Reid J, van Weel C, et al. Allergic rhinitis management pocket reference 2008. Allergy 63:990-996, 2008.
13. Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) guidelines: Management of allergic rhinitis. Prim Care Respir J 15:58-70, 2006.
14. Waddell AN, Patel SK, Toma AG, et al. Intranasal steroid sprays in the treatment of rhinitis: Is one better than another? J Laryngol Otol 117:843-845, 2003.
15. Martin BG, Ratner PH, Hampel FC, et al. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 28:216-225, 2007.
16. Jacobs R, Martin B, Hampel F, et al. Effectiveness of fluticasone furoate 110 mug once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Curr Med Res Opin 26: 1393-1401, 2009. (Epub ahead of print May 6, 2009.)
17. Fokkens WJ, Jogi R, Reinartz S, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 62:1078-1084, 2007.
18. Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 119:1430-1437, 2007.
19. Meltzer EO, Lee J, Tripathy I, et al. Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatr Allergy Immunol 20:279-286, 2009.
20. Andrews CP, Martin BG, Jacobs RL, et al. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Allergy Asthma Proc 30:128-138, 2009.
21. Keith PK, and Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin 25:2021-2041, 2009.
22. Baroody FM, Shenaq D, DeTineo M, et al. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol 123:1342-1348, 2009.
23. Garris C, Shah M, D'Souza A, and Stanford R. Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: Retrospective cohort analysis of pharmacy claims data. Clin Drug Investig 29:515-526, 2009.